Literature DB >> 25422123

Membrane interactions of synthetic peptides with antimicrobial potential: effect of electrostatic interactions and amphiphilicity.

Matthieu Fillion1, Geneviève Valois-Paillard, Aurélien Lorin, Mathieu Noël, Normand Voyer, Michèle Auger.   

Abstract

Cationic antimicrobial peptides are considered promising candidates to complement currently used antibiotics, which are less effective against increasingly resistant pathogens. To determine the mechanism of action of these peptides, a better understanding of each molecular determinant involved in their membrane interactions is of great importance. In this study, we have focused on the role of electrostatic interactions and amphiphilicity on the membrane interactions since the large majority of natural antimicrobial peptides are cationic. Therefore, cationic and anionic peptides have been prepared based on a model 14-mer peptide. The latter is a synthetic peptide composed of ten leucines and four phenylalanines, which are modified by the addition of the crown ether. Infrared spectroscopy results indicate that the position of substitution is the main determinant involved in the secondary structure adopted by the peptides, and not the charge of the substituted residues. Fluorescence vesicle leakage assays indicate, however, differences between the ability of cationic and anionic peptides to induce calcein release in zwitterionic and anionic lipid vesicles, suggesting an importance of electrostatic interactions and repulsions. Finally, (31)P NMR results indicate that the vesicle morphologies is not significantly affected by the interactions with both cationic and anionic peptides but that their effect on lipid bilayers is mainly determined by their secondary structure. This study therefore indicates that the membrane interactions of model 14-mer peptides are mainly governed by their secondary structure, which depends on the position of substitution, and not the charge of the residues.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25422123     DOI: 10.1007/s12602-014-9177-z

Source DB:  PubMed          Journal:  Probiotics Antimicrob Proteins        ISSN: 1867-1306            Impact factor:   4.609


  34 in total

Review 1.  Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides.

Authors:  Y Shai
Journal:  Biochim Biophys Acta       Date:  1999-12-15

2.  Dermcidin: a novel human antibiotic peptide secreted by sweat glands.

Authors:  B Schittek; R Hipfel; B Sauer; J Bauer; H Kalbacher; S Stevanovic; M Schirle; K Schroeder; N Blin; F Meier; G Rassner; C Garbe
Journal:  Nat Immunol       Date:  2001-12       Impact factor: 25.606

3.  Membrane disruption ability of facially amphiphilic helical peptides.

Authors:  Yvonne R Vandenburg; Bradley D Smith; Eric Biron; Normand Voyer
Journal:  Chem Commun (Camb)       Date:  2002-08-21       Impact factor: 6.222

Review 4.  The interaction of the antimicrobial peptide gramicidin S with lipid bilayer model and biological membranes.

Authors:  E J Prenner; R N Lewis; R N McElhaney
Journal:  Biochim Biophys Acta       Date:  1999-12-15

5.  Insights on the interactions of synthetic amphipathic peptides with model membranes as revealed by 31P and 2H solid-state NMR and infrared spectroscopies.

Authors:  Marise Ouellet; Geneviève Bernard; Normand Voyer; Michèle Auger
Journal:  Biophys J       Date:  2006-03-13       Impact factor: 4.033

Review 6.  Cationic peptides: a new source of antibiotics.

Authors:  R E Hancock; R Lehrer
Journal:  Trends Biotechnol       Date:  1998-02       Impact factor: 19.536

7.  An 'Upp'-turn in bacteriocin receptor identification.

Authors:  Paul D Cotter
Journal:  Mol Microbiol       Date:  2014-05-19       Impact factor: 3.501

8.  Lipid conformation in model membranes and biological membranes.

Authors:  J Seelig; A Seelig
Journal:  Q Rev Biophys       Date:  1980-02       Impact factor: 5.318

9.  Action of divergicin M35, a class IIa bacteriocin, on liposomes and Listeria.

Authors:  K Naghmouchi; D Drider; I Fliss
Journal:  J Appl Microbiol       Date:  2007-06       Impact factor: 3.772

10.  A fluorescence assay to monitor vesicle fusion and lysis.

Authors:  D A Kendall; R C MacDonald
Journal:  J Biol Chem       Date:  1982-12-10       Impact factor: 5.157

View more
  6 in total

Review 1.  Porcine Myeloid Antimicrobial Peptides: A Review of the Activity and Latest Advances.

Authors:  Shuaibing Shi; Tengfei Shen; Yongqing Liu; Liangliang Chen; Chen Wang; Chengshui Liao
Journal:  Front Vet Sci       Date:  2021-05-14

2.  A New Synthetic Peptide Having Two Target of Antibacterial Action in E. coli ML35.

Authors:  Adriana Barreto-Santamaría; Hernando Curtidor; Gabriela Arévalo-Pinzón; Chonny Herrera; Diana Suárez; Walter H Pérez; Manuel E Patarroyo
Journal:  Front Microbiol       Date:  2016-12-20       Impact factor: 5.640

Review 3.  Mechanisms of Action for Antimicrobial Peptides With Antibacterial and Antibiofilm Functions.

Authors:  Nigare Raheem; Suzana K Straus
Journal:  Front Microbiol       Date:  2019-12-12       Impact factor: 5.640

Review 4.  Host Defense Peptides: Dual Antimicrobial and Immunomodulatory Action.

Authors:  Matthew Drayton; Julia P Deisinger; Kevin C Ludwig; Nigare Raheem; Anna Müller; Tanja Schneider; Suzana K Straus
Journal:  Int J Mol Sci       Date:  2021-10-16       Impact factor: 5.923

Review 5.  Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy.

Authors:  Fatai Lu; Yingkang Zhu; Guodong Zhang; Zunpeng Liu
Journal:  Front Pharmacol       Date:  2022-08-23       Impact factor: 5.988

Review 6.  Nanomedicine Fight against Antibacterial Resistance: An Overview of the Recent Pharmaceutical Innovations.

Authors:  Nermin E Eleraky; Ayat Allam; Sahar B Hassan; Mahmoud M Omar
Journal:  Pharmaceutics       Date:  2020-02-08       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.